Quarterly report · Q2
3840.TEDINET S100SAPE
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥2.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | −¥116m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | −¥91m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | −¥114m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥224m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥101m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥101m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥101m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥104m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥256m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥102m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥104m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | −¥102m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥1.5bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥1.5bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥1.3bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥405m | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥351m | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.1bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.0bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥238m | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥173m | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥238m | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥173m | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥193m | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥345m | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥54m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥352m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥287m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥6m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥114m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥126m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥281m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥137m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-2 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.24 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.46 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.28 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.27 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 72.7% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 27
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥40m |
| jpcrp040300-q2r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥934m |
| jpcrp040300-q2r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥934m |
| jpcrp040300-q2r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥40m |
| jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥168m |
| jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥168m |
| jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1m |
| jpcrp040300-q2r_E05674-000Sustainable Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥3m |
| jpcrp040300-q2r_E05674-000Sustainable Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3m |
| jpcrp040300-q2r_E05674-000Sustainable Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥37m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥1.1bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥1.1bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | −¥76m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥200,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥200,000 |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥52m |
| jpcrp040300-q2r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.0bn |
| jpcrp040300-q2r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.0bn |
| jpcrp040300-q2r_E05674-000Cosmetics Beauty And Wellnes Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥5m |
| jpcrp040300-q2r_E05674-000Sustainable Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥300,000 |
| jpcrp040300-q2r_E05674-000Sustainable Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥100,000 |
| jpcrp040300-q2r_E05674-000Sustainable Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥200,000 |
| jpcrp040300-q2r_E05674-000Sustainable Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥34m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥1.0bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥1.0bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥200,000 |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | −¥39m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 482
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from issuance of subscription rights to shares fin cf | Prior1YTDDuration | 9494000 | JPY |
| Proceeds from issuance of subscription rights to shares fin cf | CurrentYTDDuration | - | JPY |
| Proceeds from issuance of common stock fin cf | Prior1YTDDuration | 497328000 | JPY |
| Proceeds from issuance of common stock fin cf | CurrentYTDDuration | - | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | Prior1YTDDuration | 130309000 | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | CurrentYTDDuration | 125810000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | 137132000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | 125810000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -152685000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 65192000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 345477000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 172881000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 192792000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 238074000 | JPY |
| Payroll and allowances sga | Prior1YTDDuration | 105336000 | JPY |
| Payroll and allowances sga | CurrentYTDDuration | 119283000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 13169000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 16739000 | JPY |
| Promotion expenses sga | Prior1YTDDuration | 83491000 | JPY |
| Promotion expenses sga | CurrentYTDDuration | 121682000 | JPY |
| Advertising expenses sga | Prior1YTDDuration | 5771000 | JPY |
| Advertising expenses sga | CurrentYTDDuration | 4947000 | JPY |
| Packing and transportation expenses sga | Prior1YTDDuration | 86412000 | JPY |
| Packing and transportation expenses sga | CurrentYTDDuration | 70412000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | 246000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | -296000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05674-000CosmeticsBeautyAndWellnesBusinessReportableSegmentsMember | 1006866000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05674-000RegenerativeMedicineRelatedBusinessReportableSegmentsMember | - | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05674-000SustainableBusinessReportableSegmentsMember | 100000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 1006966000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | Prior1YTDDuration | 1006966000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05674-000CosmeticsBeautyAndWellnesBusinessReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05674-000RegenerativeMedicineRelatedBusinessReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05674-000SustainableBusinessReportableSegmentsMember | 200000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 200000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -200000 | JPY |
| Transactions with other segments | Prior1YTDDuration | - | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05674-000CosmeticsBeautyAndWellnesBusinessReportableSegmentsMember | 1006866000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05674-000RegenerativeMedicineRelatedBusinessReportableSegmentsMember | - | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05674-000SustainableBusinessReportableSegmentsMember | 300000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 1007166000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -200000 | JPY |
| Net sales | Prior1YTDDuration | 1006966000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05674-000CosmeticsBeautyAndWellnesBusinessReportableSegmentsMember | -4947000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05674-000RegenerativeMedicineRelatedBusinessReportableSegmentsMember | - | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05674-000SustainableBusinessReportableSegmentsMember | -33742000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | -38689000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -51974000 | JPY |
| Operating income | Prior1YTDDuration | -90664000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |